Polyglutamine neurodegenerative diseases result from the expansion of a trinucleotide CAG repeat, encoding a polyglutamine tract in the disease-causing protein. The process by which each polyglutamine protein exerts its toxicity is complex, involving a variety of mechanisms including transcriptional dysregulation, proteasome impairment and mitochondrial dysfunction. Thus, the most effective and widely applicable therapies are likely to be those designed to eliminate production of the mutant p...Expand abstract
- Publisher copy:
- Copyright date:
RNA therapy for polyglutamine neurodegenerative diseases.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record